2930 results
Management of adult IgA Vasculitis (Henoch-Schönlein purpura) - Treatment algorithm for the management of IgAV patients
algorithm for the ... the long-term outcome ... Treatment remains ... improved long-term outcome ... Rheumatology #Vasculitis #Algorithm
Global Alliance algorithm to improve outcomes in acne.
†With small nodules (>0.5–1 cm).
‡Consider physical removal of comedones.
§Second
Global Alliance algorithm ... to improve outcomes ... PrimaryCare #Acne #Treatment ... #Algorithm
The goals of #COPD #treatment include recognizing the impact that both #symptoms and #exacerbations have on
goals of #COPD #treatment ... for monitoring treatment ... outcomes and adjusting ... #management #algorithm
The rationale for aggressive treatment of generalized status epilepticus was described previously here.  In short,
for aggressive treatment ... In short, best outcomes ... Refractory #Seizures #Algorithm
Interventional bronchoscopic and surgical treatments for chronic obstructive pulmonary disease (COPD). Overview of various therapies used
bronchoscopic and surgical treatments ... other long-term outcomes ... VolumeReduction #Bullectomy #Algorithm
Cerebral Venous Thrombosis (CVT) - Management Algorithm
Prognostic score for CVT:
Variables: Malignancy 2, Coma 2, Deep venous
) - Management Algorithm ... Low risk of poor outcome ... High risk of poor outcome ... Thrombosis #Management #Algorithm
Suggested Treatment Algorithms for the Management of Polymyalgia Rheumatica and Giant Cell Arteritis

#Management #Algorithm #GCA #PMR
Suggested Treatment ... Algorithms for ... #Management #Algorithm ... Steroid #Taper #Treatment
ESICM LIVES 2019 session on Post Cardiac Arrest Care.
Summary and infographic by Tommaso Scquizzato (@tscquizzato): https://www.esicm.org/blog/?p=2337

Topics
Patient outcome ... Heamodynamics #Monitoring #Outcomes
COPD Exacerbations - Management
 • Identify Triggers
 • Assess Severity
 • Risk for Poor Outcomes
 •
Risk for Poor Outcomes ... • Initial Treatment ... Exacerbation #Management #treatment
Selected Clinical Trials of SGLT2 inhibitors in CVD and CKD
EMPA-REG OUTCOME - Empagliflozin lowered CV events
and CKD EMPA-REG OUTCOME ... T2DM; first renal outcomes ... Dapagliflozin improved HF outcomes ... Empagliflozin improved HF outcomes